Interferons are signalling proteins that change how cells respond to infection, stress and immune activity. There are three families with different receptors, and a short exposure, a long exposure and a missing response can each mean something different for a tumour.
Type I interferons (alpha and beta) share a receptor system found on many cell types. Type II (gamma) uses a different receptor system and is made mainly by activated immune cells. The type I receptor, IFNAR, is expressed on virtually all nucleated cells and the type III receptor mainly on epithelial cells (Lazear et al., 2019), and interferon gamma production is largely restricted to immune cells although its receptor is widely expressed (Schneider et al., 2014). Interferon gamma effects include upregulated antigen processing and presentation and an antiviral state (Schroder et al., 2004). Type III (lambda) signals through a distinct receptor complex, made of IFN-lambda receptor 1 and IL-10 receptor 2, that signals through the Jak-STAT pathway (Kotenko et al., 2003); in mice the response to lambda was prominent in stomach, intestine and lung, very low in the brain and spleen, and restricted to epithelial cells in kidney and brain (Sommereyns et al., 2008). Types I, II and III group interferons by receptor usage; the alpha, beta, gamma and lambda names do not measure dose or potency. Many responses run through JAK and STAT proteins and can increase antigen-processing and HLA machinery, antiviral defences, or regulatory signals; producing an interferon, receiving it and carrying out a function are separate steps.
In plain words · The receptor through which interferon alpha alerts immune cells and slows tumour growth. Interferon was one of the first immunotherapies, used in melanoma, hairy cell leukaemia and chronic myeloid leukaemia, and has largely given way to targeted drugs and checkpoint inhibitors.
Showing the target this term concerns: Interferon alpha receptor (IFNAR1).
Shares Interferon alpha receptor (IFNAR1), Cytokine, JAK2.
Shares Interferon-gamma gene signature (T-cell-inflamed signature), JAK1, JAK2.
Shares Interferon alpha receptor (IFNAR1), Cytokines & engineered cytokines.
Shares Cytokine, Immune system.
Shares Interferon alpha receptor (IFNAR1), Cytokines & engineered cytokines.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/